Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Morehouse School of Medicine Prevention Research Center: Advancing Health Equity through Community-Led Applied Public Health Prevention Research and Translation
Tribes and Tribal Organizations
Interdisciplin Training-Genetics &Complex Disease(RMI)
General Clinical Research Center
Role of Brain Monoamines and Lh and Prolactin
Recently added grants:
Modeling and analysis of the mechanochemical processes that govern clathrin-mediated endocytosis
Correction of endocrine disruptor-induced transgenerational epimutations by CRISPR-dCas9
Gap Junctional Patterning in the Arrhythmic Heart
Role of RhoA in the Molecular Pathogenesis of Heart Disease.
Axes of Oncometabolism in the Heart
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07160-32-0-1
Application #
7575499
Study Section
Project Start
2000-08-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ Clinical Trials and Surveys Corporation
$1,684,146
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial - Mcc
Thompson, Bruce W. /
$250,000
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant